BioCentury | Apr 15, 2013
Company News

LJL board of directors update

...BioSystems Inc. , Sunnyvale, Calif. Business: Enabling technology Appointed: Michael Bigham, president and CEO of Coulter Pharmaceutical Inc....
BioCentury | Mar 25, 2013
Finance

Done with biotech

Done with biotech Three Arch Partners has made only a handful of biotech investments since its formation in 1993, and it is not looking for any more. The VC said last week it has no...
BioCentury | Apr 30, 2007
Strategy

Scale was elusive

...top selling protease inhibitor for HIV. Companies with late-stage cancer compounds had also disappeared, including Coulter Pharmaceutical Inc....
BioCentury | Dec 8, 2003
Regulation

PDUFA: Time stands still

...behind closed doors and are never made public. Bexxar, a radiolabeled MAb originally developed by Coulter Pharmaceutical Inc....
BioCentury | Mar 3, 2003
Company News

Corixa, Idec, GlaxoSmithKline cancer news

...September 2001. At that time, IDPH filed two suits: the first was against CRXA, CRXA's Coulter Pharmaceutical Inc....
BioCentury | Dec 23, 2002
Product Development

Deconstructing Bexxar

...Rituxan . But one still could argue that the bet was lost: The original sponsor, Coulter Pharmaceutical Inc....
BioCentury | Jun 3, 2002
Company News

Deltagen management update

...Cancer, Metabolic, Autoimmune/Inflammation Hired: Geoffrey Yarranton as EVP of R&D, formerly SVP of R&D at Coulter Pharmaceutical Inc....
BioCentury | Apr 1, 2002
Clinical News

Bexxar tositumomab radiolabeled anti-CD20 monoclonal antibody regulatory update

...the FDA within the next 45 days. CRXA acquired Bexxar through its 2000 acquisition of Coulter Pharmaceutical Inc....
BioCentury | Mar 18, 2002
Clinical News

Bexxar tositumomab radiolabeled anti-CD20 monoclonal antibody regulatory update

...evidence of safety and clinical benefit. CRXA acquired Bexxar tositumomab through its 2000 acquisition of Coulter Pharmaceutical Inc....
BioCentury | Sep 17, 2001
Company News

Corixa, Idec, GlaxoSmithKline cancer news

...U.S. District Court for the Southern District of California. IDPH's first suit, against CRXA, CRXA's Coulter Pharmaceutical Inc....
Items per page:
1 - 10 of 100
BioCentury | Apr 15, 2013
Company News

LJL board of directors update

...BioSystems Inc. , Sunnyvale, Calif. Business: Enabling technology Appointed: Michael Bigham, president and CEO of Coulter Pharmaceutical Inc....
BioCentury | Mar 25, 2013
Finance

Done with biotech

Done with biotech Three Arch Partners has made only a handful of biotech investments since its formation in 1993, and it is not looking for any more. The VC said last week it has no...
BioCentury | Apr 30, 2007
Strategy

Scale was elusive

...top selling protease inhibitor for HIV. Companies with late-stage cancer compounds had also disappeared, including Coulter Pharmaceutical Inc....
BioCentury | Dec 8, 2003
Regulation

PDUFA: Time stands still

...behind closed doors and are never made public. Bexxar, a radiolabeled MAb originally developed by Coulter Pharmaceutical Inc....
BioCentury | Mar 3, 2003
Company News

Corixa, Idec, GlaxoSmithKline cancer news

...September 2001. At that time, IDPH filed two suits: the first was against CRXA, CRXA's Coulter Pharmaceutical Inc....
BioCentury | Dec 23, 2002
Product Development

Deconstructing Bexxar

...Rituxan . But one still could argue that the bet was lost: The original sponsor, Coulter Pharmaceutical Inc....
BioCentury | Jun 3, 2002
Company News

Deltagen management update

...Cancer, Metabolic, Autoimmune/Inflammation Hired: Geoffrey Yarranton as EVP of R&D, formerly SVP of R&D at Coulter Pharmaceutical Inc....
BioCentury | Apr 1, 2002
Clinical News

Bexxar tositumomab radiolabeled anti-CD20 monoclonal antibody regulatory update

...the FDA within the next 45 days. CRXA acquired Bexxar through its 2000 acquisition of Coulter Pharmaceutical Inc....
BioCentury | Mar 18, 2002
Clinical News

Bexxar tositumomab radiolabeled anti-CD20 monoclonal antibody regulatory update

...evidence of safety and clinical benefit. CRXA acquired Bexxar tositumomab through its 2000 acquisition of Coulter Pharmaceutical Inc....
BioCentury | Sep 17, 2001
Company News

Corixa, Idec, GlaxoSmithKline cancer news

...U.S. District Court for the Southern District of California. IDPH's first suit, against CRXA, CRXA's Coulter Pharmaceutical Inc....
Items per page:
1 - 10 of 100